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Editor, 
Patients of African descent are disproportionately affected by both primary open‐angle glaucoma 
(POAG) (Racette et al. 2003) and Alzheimer's disease (AD) (Steenland et al. 2016) compared to 
their European counterparts. Importantly, both diseases represent chronic, age‐related and 
multifactorial neurodegenerative disorders affecting ocular and brain tissue of similar 
embryological origin. As vascular risk factors have been implicated in the pathophysiology of 
both POAG and AD, it is possible that differences in vascular pathology may account for a 
portion of the shared increased risk for both POAG and AD in patients of African descent.  
Specifically, patients with AD were reported to have a fivefold increase in glaucoma compared 
to matched controls, despite lower mean intraocular pressure, suggesting a nonpressure influence 
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on the disease (Nucci et al. 2015). It has been suggested that POAG patients of African descent 
have a stronger vascular component in their disease process, including local and systemic 
vascular and metabolism biomarkers. Recently, a four‐year prospective study identified reduced 
blood flow in the retrobulbar and retinal vasculature as predictors of glaucomatous structural 
progression in both the optic nerve head and macula, at significantly higher levels in persons of 
African compared to European descent (Siesky et al. 2016). Specific vascular changes have also 
been identified in AD including capillary dysfunction and regional capillary loss, both associated 
with cognitive deterioration (Nielsen et al. 2017). In addition, recent data suggest patients with 
AD may have changes in retinal oxygen metabolism (Stefánsson et al. 2017) as retinal oxygen 
saturation in arterioles and venules was shown to be significantly elevated in patients with 
moderate AD compared to healthy individuals (Einarsdottir et al. 2016).  
Together these findings suggest that vascular insult may be implicated as a shared mechanistic 
pathway that accounts for the disease disparity seen in both AD and POAG in persons of African 
descent. The recent advancement of ocular imaging modalities that allow for the examination of 
the microvasculature of the optic nerve, specifically ocular coherence tomography angiography 
(OCTA), may provide a useful and noninvasive biomarker differential in not only glaucoma, but 
also AD, particularly in patients of African descent. We, herein, encourage more research to 
identify these shared vascular pathways in AD and POAG so we may improve outcomes for 
persons of African descent experiencing these disease disparities. 
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